Paper817697
Clonazepam. A review of a new anticonvulsant drug.
Browne TR. Arch Neurol, 1976. Cited by 177 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clonazepam. A review of a new anticonvulsant drug. Papers, record 817697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/817697
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzodiazepinones | Major topic |
| Clonazepam | Major topic |
| Adult | |
| Brain | |
| Chemical Phenomena | |
| Chemistry | |
| Child | |
| Diazepam | |
| Drug Tolerance | |
| Electroencephalography | |
| Enzyme Induction | |
| Epilepsies, Partial | |
| Epilepsy, Absence | |
| Epilepsy, Temporal Lobe | |
| Epilepsy, Tonic-Clonic | |
| Fetus | |
| Humans | |
| Light | |
| Myoclonus | |
| Spasms, Infantile | |
| Substance-Related Disorders |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,187,637 | Clonazepam monotherapy for treating people with newly diagnosed epilepsy. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35187637 | PubMed |
| 34,811,788 | Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations. | Br J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/34811788 | PubMed |
| 32,022,673 | Use of clonazepam in REM sleep behavior disorder: association with fall-related injuries and alternative treatments. | J Clin Sleep Med | 2020 | https://conductscience.org/library/papers/32022673 | PubMed |
| 31,742,671 | Clonazepam monotherapy for treating people with newly diagnosed epilepsy. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31742671 | PubMed |
| 28,101,765 | Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview. | CNS Drugs | 2017 | https://conductscience.org/library/papers/28101765 | PubMed |
| 27,255,267 | Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review. | Pharmacol Rev | 2016 | https://conductscience.org/library/papers/27255267 | PubMed |
| 26,404,860 | Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study. | Support Care Cancer | 2016 | https://conductscience.org/library/papers/26404860 | PubMed |
| 26,140,660 | Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. | Epilepsia | 2015 | https://conductscience.org/library/papers/26140660 | PubMed |
| 25,511,520 | Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series. | J Med Case Rep | 2014 | https://conductscience.org/library/papers/25511520 | PubMed |
| 24,137,011 | The ADAR RNA editing enzyme controls neuronal excitability in Drosophila melanogaster. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/24137011 | PubMed |
| 23,425,659 | The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions. | Cell Commun Signal | 2013 | https://conductscience.org/library/papers/23425659 | PubMed |
| 21,955,162 | Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/21955162 | PubMed |
| 17,963,043 | Neuropsychological deficits in childhood epilepsy syndromes. | Neuropsychol Rev | 2007 | https://conductscience.org/library/papers/17963043 | PubMed |
| 6,956,751 | Tourette's syndrome in a black woman with associated triple X and 9p mosaicism. | J Natl Med Assoc | 1982 | https://conductscience.org/library/papers/6956751 | PubMed |
| 6,336,967 | Drug treatment of epilepsy: a review. | Can Med Assoc J | 1983 | https://conductscience.org/library/papers/6336967 | PubMed |
| 3,930,124 | Serum protein binding of tolbutamide in patients treated with antiepileptic drugs. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/3930124 | PubMed |
| 3,828,198 | N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3828198 | PubMed |
| 2,692,942 | Disposition of anticonvulsants in childhood. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2692942 | PubMed |
| 2,305,012 | Changes in seizure threshold and aggression during chronic treatment with three anticonvulsants and on drug withdrawal. | Psychopharmacology (Berl) | 1990 | https://conductscience.org/library/papers/2305012 | PubMed |
| 2,064,761 | Adverse reactions in children. Special considerations in prevention and management. | Drug Saf | 1991 | https://conductscience.org/library/papers/2064761 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/817697
GET https://conductscience.org/api/papers/v1/817697/cited_by?page=2